Table 1 Main features in participants with COPD and in controls.

From: Immune response to pertussis vaccine in COPD patients

 

Controls (n = 8)

COPD (n = 13)

Males/females

6M/2F

11M/2F

Age (years)

64 (56.25–67.75)

68 (61–70)

Pack year

24 (10–40)

55 (25.75–69)

FEV (% predicted)

102 (100–104)

57 (42.5–66.5)

FVC (% predicted)

101 (96–111)

77 (64.5–90.5)

FEV/FVC (% predicted)

81 (76.5–88)

52 (49.5–64)

DLCO (% predicted)

91 (81.5–107.5)

60 (81.5–107.5)

  1. Data are median ± interquartile range (IQR).
  2. DLCO diffusing capacity of the lung for carbon monoxide, FVC forced vital capacity, FEV forced expiratory volume.
Back to article page